These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27207913)

  • 1. Serum Cytokine Profiles of Children with Obsessive-Compulsive Disorder Shows the Evidence of Autoimmunity.
    Şimşek Ş; Yüksel T; Çim A; Kaya S
    Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 27207913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cytokine abnormalities in drug-naïve, comorbidity-free obsessive-compulsive disorder.
    Rao NP; Venkatasubramanian G; Ravi V; Kalmady S; Cherian A; Yc JR
    Psychiatry Res; 2015 Oct; 229(3):949-52. PubMed ID: 26187339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol and Brain-Derived Neurotrophic Factor Levels Prior to Treatment in Children With Obsessive-Compulsive Disorder.
    Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Alaca R
    J Clin Psychiatry; 2016 Jul; 77(7):e855-9. PubMed ID: 27314567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.
    Çolak Sivri R; Bilgiç A; Kılınç İ
    Eur Child Adolesc Psychiatry; 2018 Aug; 27(8):977-984. PubMed ID: 29302747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D levels in children and adolescents with obsessive compulsive disorder.
    Yazici KU; Percinel Yazici I; Ustundag B
    Nord J Psychiatry; 2018 Apr; 72(3):173-178. PubMed ID: 29168423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity.
    Scahill L; Riddle MA; McSwiggin-Hardin M; Ort SI; King RA; Goodman WK; Cicchetti D; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):844-52. PubMed ID: 9183141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting.
    Yucelen AG; Rodopman-Arman A; Topcuoglu V; Yazgan MY; Fisek G
    Compr Psychiatry; 2006; 47(1):48-53. PubMed ID: 16324902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.
    Anagnostopoulos DC; Korlou S; Sakellariou K; Kondyli V; Sarafidou J; Tsakanikos E; Giannakopoulos G; Liakopoulou M
    Psychiatriki; 2016; 27(1):27-36. PubMed ID: 27110880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Study of Neurological Soft Signs in Patients with Schizophrenia or Obsessive-compulsive Disorder, and Healthy Controls.
    Tripathi R; Soni A; Tyagi A; Mehta S; Gupta S
    East Asian Arch Psychiatry; 2015 Jun; 25(2):64-72. PubMed ID: 26118745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cytokine study of adult patients with obsessive-compulsive disorder.
    Fontenelle LF; Barbosa IG; Luna JV; de Sousa LP; Abreu MN; Teixeira AL
    Compr Psychiatry; 2012 Aug; 53(6):797-804. PubMed ID: 22300901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IL-4 and IL-10 Levels Correlate with the Symptoms of the Drug-Naive Adolescents with First Episode, Early Onset Schizophrenia.
    Şimşek Ş; Yıldırım V; Çim A; Kaya S
    J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):721-726. PubMed ID: 27384868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between metacognitions and insight in obsessive-compulsive disorder.
    Önen S; Karakaş Uğurlu G; Çayköylü A
    Compr Psychiatry; 2013 Jul; 54(5):541-8. PubMed ID: 23312877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obsessive-compulsive symptoms in children and pre-adolescents: clinical observation of inpatients].
    Minami T
    Seishin Shinkeigaku Zasshi; 1998; 100(2):92-112. PubMed ID: 9584573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adiponectin and resistin levels in patients with obsessive compulsive disorder.
    Ari M; Ozturk OH; Bez Y; Arica S; Can Y; Erduran D
    J Affect Disord; 2012 Feb; 136(3):979-82. PubMed ID: 22119090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder.
    Monteleone P; Catapano F; Fabrazzo M; Tortorella A; Maj M
    Neuropsychobiology; 1998; 37(4):182-5. PubMed ID: 9648125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and clinical features of obsessive-compulsive disorder in children and adolescents.
    Hanna GL
    J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):19-27. PubMed ID: 7860451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sociodemographic and clinical characteristics of Turkish children and adolescents with obsessive-compulsive disorder.
    Diler RS; Avci A
    Croat Med J; 2002 Jun; 43(3):324-9. PubMed ID: 12035140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder.
    Konuk N; Tekin IO; Ozturk U; Atik L; Atasoy N; Bektas S; Erdogan A
    Mediators Inflamm; 2007; 2007():65704. PubMed ID: 17497035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum folate and homocysteine levels in patients with obsessive-compulsive disorder.
    Atmaca M; Tezcan E; Kuloglu M; Kirtas O; Ustundag B
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):616-20. PubMed ID: 16194269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.